With Autologous Micrograft Technology®, Rigenera uses autologous and homologous cells to activate hair follicles in the treatment of androgenetic alopecia, through a simple and risk-free process with great therapeutic potential for patients. The AMT® protocols are based on stimulating self-regeneration by activating native progenitor cells located in homologous tissues.